 |
|
 |
|
 |
|
|
|
|
 |
|
|
|
|
|
| • |
It's Summer, Get Ready for Diabetes Camp!
By Gregory P. Forlenza, MD; and Michael J. Haller, MD, MS-CI |
| • |
Precocious Puberty: Apects of Diagnosis and Treatment
By Jakub Mieszczak, MD; and Peter A. Lee, MD |
| • |
Options and Outcomes of CPP Treatment
By Lawrence A. Silverman, MD |
| • |
Multimodal Childhood Obesity Treatment Programs: An Evidence-Based Review
By Sarah Armstrong, MD |
| • |
The Physiology of Human Growth: A Review
By Arlan L. Rosenbloom, MD |
| • |
Treatment, Dosing, and Follow-Up of Children With Primary and Secondary IGFD
By Barry B. Bercu, MD |
|
|
|
 |
|
|
 |
 |
|
| Review of ENDOCRINOLOGY provides diabetes and endocrine specialists with practical insight regarding the issues, treatments and emerging trends in diabetes and endocrine disorders. It will help put into perspective what the scientific developments mean to today's practice and will discuss ramifications of new studies, treatments and patient management strategies. |
|
|
|
|
 |
|
|
|
|
Not on our mailing list? Click the button below to recieve the newest issue of Review of ENDOCRINOLOGY
|
 |
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
 The FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study sought to investigate whether long-term lipid-lowering therapy with fenofibrate would reduce macro- and microvascular complications among patients with type 2 diabetes. |
 |
|
|
|
|
|
|
